Literature DB >> 6950027

Effects of estradiol on norepinephrine and prostaglandin efflux in medial basal hypothalamus of ovariectomized rats.

D P Cardinali, J Fernández Pardal, M F Gimeno, A L Gimeno.   

Abstract

The spontaneous and K+-stimulated efflux of norepinephrine (NE) and the release of PGE2 and PGF2 alpha were examined in medial basal hypothalamus (MBH) of ovariectomized rats killed before and during the LH release that follows estradiol treatment. As compared to vehicle-treated, ovariectomized rats, estradiol-primed rats exhibited a 60% more increase in K+-stimulated 3H-overflow of MBH slices preloaded with 3H-NE at morning hours (1000 hours). Estradiol treatment did not result in further increase of K+-induced 3H release from MBH slices at the time of LH release (1700 hours), nor affected labeled NE release in occipital cortex slices. A significant difference between K+-stimulated NE release of vehicle-treated spayed rats killed at 1000 and 1700 hours was observed, the latter showing 54% more release upon stimulus. PGE2 efflux was time-dependent being highest at the evening in both vehicle- and estradiol-treated animals. The MBH of estrogenized rats released significantly more PGE2 at the evening as compared to the controls. The release of PGF2 alpha remained essentially unchanged regardless of estradiol treatment or time of day. The present results offer additional support to the involvement of MBH catecholamines and prostaglandins in the mechanism of LH secretion in the rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6950027     DOI: 10.1007/bf01243518

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  19 in total

Review 1.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

2.  Effects of estradiol benzoate on catecholamine levels and turnover in discrete areas of the medium eminence and the limbic forebrain, and on serum luteinizing hormone, follicle stimulating hormone and prolactin concentrations in the ovariectomized female rat.

Authors:  A Löfstöm; P Eneroth; J A Gustafsson; P Skett
Journal:  Endocrinology       Date:  1977-11       Impact factor: 4.736

3.  Release of prostaglandin Es by hypothalamic tissue: evidence for their involvement in catecholamine-induced luteinizing hormone-releasing hormone release.

Authors:  S R Ojeda; A Negro-Vilar; S M McCann
Journal:  Endocrinology       Date:  1979-03       Impact factor: 4.736

4.  Pituitary-ovarian interrelationships in the rat.

Authors:  J D Neill; M S Smith
Journal:  Curr Top Exp Endocrinol       Date:  1974

5.  Effects of a single injection of an estrogen antagonist on the estrous cycle of the rat.

Authors:  B Shirley; J Wolinsky; N B Schwartz
Journal:  Endocrinology       Date:  1968-05       Impact factor: 4.736

6.  Release of luteinizing hormone induced by estrogen injection into ovariectomized rats.

Authors:  L Caligaris; J J Astrada; S Taleisnik
Journal:  Endocrinology       Date:  1971-04       Impact factor: 4.736

7.  Increased turnover of 3H-norepinephrine in rat brain following castration or treatment with ovine follicle-stimulating hormone.

Authors:  F Anton-Tay; R W Pelham; R J Wurtman
Journal:  Endocrinology       Date:  1969-06       Impact factor: 4.736

8.  Changes in hypothalamic noradrenaline, dopamine and serotonin uptake after oestradiol administration to rats.

Authors:  D P Cardinali; E Gómez
Journal:  J Endocrinol       Date:  1977-04       Impact factor: 4.286

9.  Dextro-phenylalanine inhibits potassium-evoked 3H-noradrenaline release from hypothalamus but not of 3H-dopamine from rat caudate nucleus.

Authors:  J F Pardal
Journal:  J Neurosci Res       Date:  1980       Impact factor: 4.164

10.  Prostaglandin F2alpha production by the brain during estrogen-induced secretion of luteinizing hormone.

Authors:  J S Roberts; J A McCracken
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.